CombiMatrix Targeted Array for Prenatal Analysis

CombiMatrix has launched its Targeted Array for Prenatal Analysis. The new microarray-based test is designed to detect clinically relevant microdeletion and microduplication disorders while minimizing the risk of identifying a variant of uncertain significance in chorionic villus sampling and amniocentesis samples.